Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (831-840 of 933) with videos related to

Pageof 94
Sort By:
Science Translational Medicine|July 8, 2026
Cytokine-mediated activation of kidney-infiltrating CD8<sup>+</sup> T cells enables their contribution to inflammation in human lupus nephritisChristopher M Skopnik, Jan Klocke, Paul Freund, et al.
Cancer Immunology Research|April 17, 2019
The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer SubtypesCarolin Pfannstiel, Pamela L Strissel, Katherine B Chiappinelli, et al.
Journal for Immunotherapy of Cancer|January 26, 2022
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancerMarkus Hecht, Markus Eckstein, Sandra Rutzner, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2022
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinomaNiklas Klümper, Danijel Sikic, Jonas Saal, et al.
Clinical Genitourinary Cancer|August 12, 2020
Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter StudyFranziska Erlmeier, Sandra Steffens, Christine Stöhr, et al.
Cancers|September 28, 2021
Reproducibility of mRNA-Based Testing of <i>ESR1</i>, <i>PGR</i>, <i>ERBB2</i>, and <i>MKI67</i> Expression in Invasive Breast Cancer-A Europe-Wide External Quality AssessmentRamona Erber, Arndt Hartmann, Peter Andreas Fasching, et al.
British Journal of Cancer|November 29, 2024
Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomasFabian Stögbauer, Markus Wirth, Maren Lauterbach, et al.
Gut|November 6, 2019
STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosisChristina Heichler, Kristina Scheibe, Anabel Schmied, et al.
Genome Medicine|September 15, 2022
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapyFlorian A Büttner, Stefan Winter, Viktoria Stühler, et al.
World Journal of Urology|July 1, 2021
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survivalFrancesco Claps, Maaike W van de Kamp, Roman Mayr, et al.
Pageof 94

Showing results (831-840 of 933) with videos related to

Sort By:
Pageof 94
Science Translational Medicine|July 8, 2026
Cytokine-mediated activation of kidney-infiltrating CD8<sup>+</sup> T cells enables their contribution to inflammation in human lupus nephritisChristopher M Skopnik, Jan Klocke, Paul Freund, et al.
Cancer Immunology Research|April 17, 2019
The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer SubtypesCarolin Pfannstiel, Pamela L Strissel, Katherine B Chiappinelli, et al.
Journal for Immunotherapy of Cancer|January 26, 2022
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancerMarkus Hecht, Markus Eckstein, Sandra Rutzner, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2022
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinomaNiklas Klümper, Danijel Sikic, Jonas Saal, et al.
Clinical Genitourinary Cancer|August 12, 2020
Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter StudyFranziska Erlmeier, Sandra Steffens, Christine Stöhr, et al.
Cancers|September 28, 2021
Reproducibility of mRNA-Based Testing of <i>ESR1</i>, <i>PGR</i>, <i>ERBB2</i>, and <i>MKI67</i> Expression in Invasive Breast Cancer-A Europe-Wide External Quality AssessmentRamona Erber, Arndt Hartmann, Peter Andreas Fasching, et al.
British Journal of Cancer|November 29, 2024
Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomasFabian Stögbauer, Markus Wirth, Maren Lauterbach, et al.
Gut|November 6, 2019
STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosisChristina Heichler, Kristina Scheibe, Anabel Schmied, et al.
Genome Medicine|September 15, 2022
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapyFlorian A Büttner, Stefan Winter, Viktoria Stühler, et al.
World Journal of Urology|July 1, 2021
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survivalFrancesco Claps, Maaike W van de Kamp, Roman Mayr, et al.
Pageof 94